Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure.

Дата публикации: 27-08-2026 00:00:00

IntroductionGiven mounting calls to disclose biomarker test results to research participants, we explored factors underlying decisions by patients with mild cognitive impairment to receive amyloid imaging results.MethodsProspective, qualitative interviews were conducted with 59 participants (30 = mild cognitive impairment patients, 29 = care partners) from the scan arm of a randomized controlled trial on the effects of amyloid PET results disclosure in an Alzheimer Disease Research Center setting.ResultsSixty-three percent of the participants were female, with an average age of 72.9 years, and most had greater than a high school level of education (80%). Primary motivations included: (1) better understanding ones mild cognitive impairment etiology and prognosis to plan ahead, and (2) learning ones brain amyloid status for knowledges sake, regardless of whether the information is actionable. Most participants demonstrated an adequate...

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	White Matter Hyperintensities in Alzheimer Disease	0	6.14	01-12-2023
2	Differences in Cognitive Aging Assessments Associated With Retest Effects	0	4.75	12-08-2026
3	Exploratory Tau Biomarker Results From a Study of BIIB080 in Alzheimer Disease	0	10.76	01-12-2023
4	Expert consensus on intracranial vessel wall MRI in cerebrovascular disease: Society for Magnetic Resonance Angiography recommendations	0	5.04	27-08-2026
5	APOE ε4‐related blood–brain barrier disruption and APOE ε4‐independent microstructural abnormalities in white matter hyperintensities	0	6.46	27-08-2026
6	Patient Perspectives on AI-Drafted Electronic Portal Messages	0	13.29	07-07-2026
7	Выявлен маркер сниженного риска болезни Альцгеймера	0	10	27-08-2026
8	Decentralized clinical trials expand access for rural and underserved patients	7	8	20-07-2026
9	Reassurance through normalization inadvertently suppresses treatment	0	8.98	27-08-2026
10	Et si on pouvait un jour intervenir, avant l’apparition des premiers symptômes, chez les personnes à haut risque de développer la maladie d’Alzheimer	0	12.88	17-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.22. Источник: escholarship.org.